These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30503917)
1. Targeting inflammatory components in neuropathic pain: The analgesic effect of thymulin related peptide. Safieh-Garabedian B; Nomikos M; Saadé N Neurosci Lett; 2019 May; 702():61-65. PubMed ID: 30503917 [TBL] [Abstract][Full Text] [Related]
2. The role of glia and the immune system in the development and maintenance of neuropathic pain. Vallejo R; Tilley DM; Vogel L; Benyamin R Pain Pract; 2010; 10(3):167-84. PubMed ID: 20384965 [TBL] [Abstract][Full Text] [Related]
3. Dual peripheral actions of immune cells in neuropathic pain. Machelska H Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):11-24. PubMed ID: 21234811 [TBL] [Abstract][Full Text] [Related]
4. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. Safieh-Garabedian B; Dardenne M; Pléau JM; Saadé NE Br J Pharmacol; 2002 Jul; 136(6):947-55. PubMed ID: 12110619 [TBL] [Abstract][Full Text] [Related]
5. Inflammation in the pathophysiology of neuropathic pain. Sommer C; Leinders M; Üçeyler N Pain; 2018 Mar; 159(3):595-602. PubMed ID: 29447138 [TBL] [Abstract][Full Text] [Related]
6. Importance of glial activation in neuropathic pain. Mika J; Zychowska M; Popiolek-Barczyk K; Rojewska E; Przewlocka B Eur J Pharmacol; 2013 Sep; 716(1-3):106-19. PubMed ID: 23500198 [TBL] [Abstract][Full Text] [Related]
7. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. Austin PJ; Moalem-Taylor G J Neuroimmunol; 2010 Dec; 229(1-2):26-50. PubMed ID: 20870295 [TBL] [Abstract][Full Text] [Related]
8. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways. Nasseri B; Zaringhalam J; Daniali S; Manaheji H; Abbasnejad Z; Nazemian V Int Immunopharmacol; 2019 May; 70():225-234. PubMed ID: 30851702 [TBL] [Abstract][Full Text] [Related]
9. Immune and inflammatory mechanisms in neuropathic pain. Moalem G; Tracey DJ Brain Res Rev; 2006 Aug; 51(2):240-64. PubMed ID: 16388853 [TBL] [Abstract][Full Text] [Related]
10. Role of thymulin or its analogue as a new analgesic molecule. Dardenne M; Saade N; Safieh-Garabedian B Ann N Y Acad Sci; 2006 Nov; 1088():153-63. PubMed ID: 17192563 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological Regulation of Neuropathic Pain Driven by Inflammatory Macrophages. Kiguchi N; Kobayashi D; Saika F; Matsuzaki S; Kishioka S Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104252 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Thacker MA; Clark AK; Marchand F; McMahon SB Anesth Analg; 2007 Sep; 105(3):838-47. PubMed ID: 17717248 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. Tao L; Ding Q; Gao C; Sun X Int Immunopharmacol; 2016 May; 34():165-172. PubMed ID: 26953646 [TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation and the generation of neuropathic pain. Ellis A; Bennett DL Br J Anaesth; 2013 Jul; 111(1):26-37. PubMed ID: 23794642 [TBL] [Abstract][Full Text] [Related]
20. Can modulating inflammatory response be a good strategy to treat neuropathic pain? Zhang J; Echeverry S; Lim TK; Lee SH; Shi XQ; Huang H Curr Pharm Des; 2015; 21(7):831-9. PubMed ID: 25345609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]